IMRN – Immuron Limited ADR
Immuron LimitedIMRN
$1.78Name : Immuron Limited
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $10,196,979.00
EPSttm : -0.81
Immuron Limited
$1.78
1.66%$0.03Float Short %
0.35
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
EPS Last/This Y
0.77
EPS This/Next Y
Price
1.72
Target Price
5
Analyst Recom
1
Performance Q
-11
Relative Volume
0.38
Beta
Ticker: IMRN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-03-05 | IMRN | 1.8 | N/A | N/A | 0 |
| 2025-03-06 | IMRN | 1.76 | N/A | N/A | 0 |
| 2025-03-07 | IMRN | 1.7612 | N/A | N/A | 0 |
| 2025-03-10 | IMRN | 1.78 | N/A | N/A | 0 |
| 2025-03-11 | IMRN | 1.79 | N/A | N/A | 0 |
| 2025-03-12 | IMRN | 1.831 | N/A | N/A | 0 |
| 2025-03-13 | IMRN | 1.8161 | N/A | N/A | 0 |
| 2025-03-14 | IMRN | 1.82 | N/A | N/A | 0 |
| 2025-03-17 | IMRN | 1.71 | N/A | N/A | 0 |
| 2025-03-18 | IMRN | 1.77 | N/A | N/A | 0 |
| 2025-03-19 | IMRN | 1.7925 | N/A | N/A | 0 |
| 2025-03-20 | IMRN | 1.81 | N/A | N/A | 0 |
| 2025-03-21 | IMRN | 1.78 | N/A | N/A | 0 |
| 2025-03-24 | IMRN | 1.85 | N/A | N/A | 0 |
| 2025-03-25 | IMRN | 1.8 | N/A | N/A | 0 |
| 2025-03-26 | IMRN | 1.8 | N/A | N/A | 0 |
| 2025-03-27 | IMRN | 1.8 | N/A | N/A | 0 |
| 2025-03-28 | IMRN | 1.89 | N/A | N/A | 0 |
| 2025-03-31 | IMRN | 1.7766 | N/A | N/A | 0 |
| 2025-04-01 | IMRN | 1.75 | N/A | N/A | 0 |
| 2025-04-02 | IMRN | 1.75 | N/A | N/A | 0 |
| 2025-04-03 | IMRN | 1.8 | N/A | N/A | 0 |
| 2025-04-04 | IMRN | 1.7 | N/A | N/A | 0 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-03-05 | IMRN | 1.90 | - | - | 0.00 |
| 2025-03-06 | IMRN | 1.90 | - | - | 0.00 |
| 2025-03-07 | IMRN | 1.76 | - | - | 0.00 |
| 2025-03-10 | IMRN | 1.76 | - | - | 0.00 |
| 2025-03-11 | IMRN | 1.83 | - | - | 0.00 |
| 2025-03-12 | IMRN | 1.78 | - | - | 0.00 |
| 2025-03-13 | IMRN | 1.82 | - | - | 0.00 |
| 2025-03-14 | IMRN | 1.82 | - | - | 0.00 |
| 2025-03-17 | IMRN | 1.82 | - | - | 0.00 |
| 2025-03-18 | IMRN | 1.77 | - | - | 0.00 |
| 2025-03-19 | IMRN | 1.79 | - | - | 0.00 |
| 2025-03-20 | IMRN | 1.81 | - | - | 0.00 |
| 2025-03-21 | IMRN | 1.91 | - | - | 0.00 |
| 2025-03-24 | IMRN | 1.80 | - | - | 0.00 |
| 2025-03-25 | IMRN | 1.80 | - | - | 0.00 |
| 2025-03-26 | IMRN | 1.80 | - | - | 0.00 |
| 2025-03-27 | IMRN | 1.80 | - | - | 0.00 |
| 2025-03-28 | IMRN | 1.85 | - | - | 0.00 |
| 2025-03-31 | IMRN | 1.80 | - | - | 0.00 |
| 2025-04-01 | IMRN | 1.75 | - | - | 0.00 |
| 2025-04-02 | IMRN | 1.75 | - | - | 0.00 |
| 2025-04-03 | IMRN | 1.80 | - | - | 0.00 |
| 2025-04-04 | IMRN | 1.72 | - | - | 0.00 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-03-05 | IMRN | 0 | -50.45 | 0.58 |
| 2025-03-06 | IMRN | 0 | -50.45 | 0.58 |
| 2025-03-07 | IMRN | 0 | -50.45 | 0.58 |
| 2025-03-10 | IMRN | 0 | -51.72 | 0.58 |
| 2025-03-11 | IMRN | 0 | -51.72 | 0.58 |
| 2025-03-12 | IMRN | 0 | -51.72 | 0.54 |
| 2025-03-13 | IMRN | 0 | -51.72 | 0.54 |
| 2025-03-14 | IMRN | 0 | -51.72 | 0.54 |
| 2025-03-17 | IMRN | 0 | -51.62 | 0.54 |
| 2025-03-18 | IMRN | 0 | -51.62 | 0.54 |
| 2025-03-19 | IMRN | 0 | -51.62 | 0.54 |
| 2025-03-20 | IMRN | 0 | -51.62 | 0.54 |
| 2025-03-21 | IMRN | 0 | -51.62 | 0.54 |
| 2025-03-24 | IMRN | 0 | -52.55 | 0.54 |
| 2025-03-25 | IMRN | 0 | -52.55 | 0.54 |
| 2025-03-26 | IMRN | 0 | -52.55 | 0.35 |
| 2025-03-27 | IMRN | 0 | -52.55 | 0.35 |
| 2025-03-28 | IMRN | 0 | -52.55 | 0.35 |
| 2025-03-31 | IMRN | 0 | -53.82 | 0.35 |
| 2025-04-01 | IMRN | 0 | -53.82 | 0.35 |
| 2025-04-02 | IMRN | 0 | -53.82 | 0.35 |
| 2025-04-03 | IMRN | 0 | -53.82 | 0.35 |
| 2025-04-04 | IMRN | 0 | -53.82 | 0.35 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
Avg. EPS Est. Current Quarter
Avg. EPS Est. Next Quarter
Insider Transactions
Institutional Transactions
-53.82
Beta
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
44
Growth Score
52
Sentiment Score
56
Actual DrawDown %
94.1
Max Drawdown 5-Year %
-92.6
Target Price
5
P/E
Forward P/E
PEG
P/S
2.41
P/B
1.59
P/Free Cash Flow
EPS
-0.85
Average EPS Est. Cur. Y
EPS Next Y. (Est.)
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
-112.26
Relative Volume
0.38
Return on Equity vs Sector %
-90.9
Return on Equity vs Industry %
-77.9
EPS 1 7Days Diff
EPS 1 30Days Diff
EBIT Estimation
Immuron LimitedSector: Healthcare
Industry: Biotechnology
Employees: 7
Immuron Limited, a biopharmaceutical company, engages in the research, development, and commercialization of polyclonal antibodies in Australia, the United States, and Canada. It operates through two segments, Research and Development; and Hyper-immune Products. The company offers Travelan, an over-the-counter medicine to reduce the risk of travelers' diarrhea and risk of minor gastrointestinal disorders, as well as a dietary supplement for digestive tract protection; and Protectyn, an immune supplement to help maintain a healthy digestive function and liver. It also develops Travelan (IMM-124E), which is in Phase II clinical trial, to reduce the risk of contracting travelers' diarrhea; and IMM-529, which is in Phase II clinical trial, for treating patients suffering from recurring clostridium difficile infection. The company has a collaboration with the US Naval Medical Research Command and Silver Spring, MD, USA to develop and clinically evaluate a therapeutic targeting Campylobacter and enterotoxigenic Escherichia coli infections; and a research collaboration with the Walter Reed Army Institute of Research to develop three Shigella-specific therapeutic products. The company was formerly known as Anadis Limited and changed its name to Immuron Limited in December 2008. Immuron Limited was incorporated in 1994 and is headquartered in Carlton, Australia.
stock quote shares IMRN – Immuron Limited ADR Stock Price stock today
news today IMRN – Immuron Limited ADR stock forecast ,stock prediction 2023 2024 2025
marketwatch IMRN – Immuron Limited ADR yahoo finance google finance
stock history IMRN – Immuron Limited ADR invest stock market
stock prices IMRN premarket after hours
ticker IMRN fair value insiders trading